.jpg)
.png)
All
A healthy diet is a powerful tool for the prevention and management of cardiovascular disease (CVD).1 Despite low-fat recommendations, the prevalence of obesity continues to increase steadily,2 because fat intake has not decreased in the United States.3 Accompanying this rise is the... more
Two new PCSK9 monoclonal antibodies have been given a nod of approval to the Food and Drug Administration (FDA). The FDA Endocrinologic and Metabolic Drugs Advisory Committee reviewed the evidence on the new class of cholesterol-lowering drugs and recommended that the FDA should approve the new... more
According to the 2011 National Diabetes fact sheet, 25.8 million adults and children in the United States (8.3%) have diabetes and 79 million have pre-diabetes. In 2010 alone, 1.9 million new cases of diabetes were diagnosed. In 2007, the total cost of diagnosed diabetes was $174 billion and... more
William Hazlitt, an 18th century literary critic and philosopher, once said, “When a thing ceases to be a subject of controversy, it ceases to be a subject of interest.”1 If one accepts his premise, then interest in high-density lipoprotein (HDL) shall endure for some time. As far as contemporary... more
This issue is sponsored by the Northeast Lipid Association. Featuring: "Evaluation of Women for the Primary Prevention of Atherosclerotic Cardiovascular Disease" "Current Understanding of the Contribution of Lipoprotein(a) to Atherosclerotic CardiovascularDisease Risk in Women" "Conventional... more
The year 2013 marks the "Silver Anniversary" of three key announcements that identified relationships among various lipid fractions, lipoproteins, apolipoproteins, non-lipid disorders and cardiovascular disease (CVD) risk. In 1988, NCEP ATP I1 recognized evidence that high levels of low... more
Featuring "Emerging Technologies And Therapeutics In Clinical Lipidology" and "Letters from the Editors – Past & Present" more
This issue sponsored by the Pacific Lipid Association Cardiovascular Risk and Dyslipidemia in Mexican-Americans Pharmacologic Treatment of Non-HDL-C and Goal Attainment
Who We Are Mission - To enhance the science and practice of lipidology and promote optimal cardiometabolic health. Consistent with the mission statement, the National Lipid Association's operating principles are: Health Equity The NLA will promote health equity in all... more
h3{ margin-bottom:10px; } The Project Review Committee The Project Review Committee will develop and review specific educational activities (CME/CE-certified and non-CME) under the direct auspices of the NLA Board of Directors and Executive Committee.... more